Find Academic Supervisors

Sandrine DudoitView profile

Professor

• Statistical Methodology
• Computational Biology
• Genomics
• +5 more

Sandrine Dudoit is a Professor and Chair of the Department of Statistics at the University of California, Berkeley. She earned her PhD in Statistics from UC Berkeley in 1999 and joined the faculty in 2001. Her research focuses on statistical methodology and computing with applications to genomics, biomedical research, and precision health. She co-founded the Bioconductor Project , an open-source software initiative for biological data analysis, and leads interdisciplinary projects in single-cell transcriptomics and computational biology. Education: PhD in Statistics (UC Berkeley, 1999), M.Sc. in Mathematics (Carleton University, Canada). Research interests include high-dimensional statistical learning, single-cell RNA-Seq analysis, stem cell differentiation in the olfactory system, and statistical computing. She collaborates with biologists like John Ngai to study neuroepithelial regeneration using cutting-edge sequencing technologies. Recent work emphasizes trajectory inference, biomarker discovery, and methodological advances in handling high-dimensional genomic data. Her lab develops tools for normalization, clustering, and differential expression analysis in large-scale biological datasets. She teaches courses on statistical genomics and serves as a leader in UC Berkeley’s Division of Computing, Data Science, and Society (CDSS). Advising: Supervises PhD students in statistical methodology, computational biology, and bioinformatics. Grants: Active in securing funding for interdisciplinary research projects in genomics and data science. Labs/Teams: Core member of the Center for Computational Biology (CCB) and contributes to the Bioconductor community.

Robert G. SalomonView profile

Professor

• Biochemistry
• Chemical Biology
• Medicinal Chemistry
• +6 more

Robert G. Salomon is the Charles Fredrick Mabery Professor of Research in Chemistry at Case Western Reserve University and holds a secondary appointment as Professor of Ophthalmology in the Department of Ophthalmology & Visual Sciences. With a career spanning over four decades at Case Western since 1973, Dr. Salomon leads the Lipid Research Group focused on understanding the role of lipid oxidation in disease processes and developing new diagnostic tools and therapeutic strategies. Dr. Salomon received his B.S. in Chemistry from the University of Chicago in 1966, followed by a Ph.D. in Organic Chemistry from the University of Wisconsin in 1971. He completed postdoctoral studies at both the University of Wisconsin and Indiana University before joining Case Western Reserve University, where he progressed from Assistant Professor to his current named professorship. Dr. Salomon's research bridges chemistry, biology, and medicine with groundbreaking work on lipid oxidation products. His laboratory discovered critically important compounds including levuglandins and isolevuglandins - highly reactive oxidized lipids that contribute to disease through reactions with proteins and DNA. His work has established connections between lipid oxidation and conditions such as age-related macular degeneration, atherosclerosis, and cancer. The research employs a multidisciplinary approach combining organic synthesis, analytical chemistry, immunology, and cell biology to investigate disease mechanisms and develop potential interventions. Analysis of Dr. Salomon's recent publications reveals a continued focus on the biochemical and pathological effects of lipid oxidation products, particularly their role in retinal diseases and cancer. His work demonstrates how compounds like HOHA lactone and carboxyethylpyrroles contribute to disease mechanisms through protein modification, inflammation, and cellular dysfunction, with significant implications for understanding disease progression and developing targeted therapies. Mortar Board 'Top Prof' Award (2003) Cleveland Clinic Innovator Award (2006) Editorial Advisory Board, Chemical Research in Toxicology (2009-) Editorial Advisory Board, Journal of Lipids (2009-) Editorial Advisory Board, Organic Chemistry International (2009-) NIH Synthetic and Biological Chemistry A Study Section (2012-16) Director, Visual Sciences Research Center Tissue Culture & Hybridoma Core (2015-) Associate Editor, Free Radical Research (2019-) Dr. Salomon's Lipid Research Group operates from the Millis Science Center at Case Western Reserve University, working in a laboratory previously occupied by Nobel Laureate George A. Olah. His laboratory features extensive capabilities for HPLC analysis, radiochemical experiments, cell culture (bacterial and mammalian), immunological studies, organic synthesis, and tissue fractionation. Through strong collaborative interactions with biomedical researchers at the CWRU School of Medicine and the Cleveland Clinic Foundation, Dr. Salomon's research extends into sophisticated mass spectroscopic analyses, animal studies, and clinical investigations on human subjects.

Mostafijur RahmanView profile

Assistant Professor

• Environmental Epidemiology
• Air Pollution
• Climate Change and Health
• +2 more

Mostafijur Rahman is an Assistant Professor of Environmental Health Sciences at Tulane University's School of Public Health and Tropical Medicine. His research leverages large environmental health datasets to study climate impacts on neurodevelopment, mental health, and cardiopulmonary outcomes. Research focuses on: Air pollution impacts on autism spectrum disorders Health effects of extreme heat and air pollution co-exposures Environmental justice and health disparities Climate vulnerability in urban populations Recent publications analyze prenatal exposures to particulate matter, mortality risks from extreme temperatures, and adaptation strategies in vulnerable communities. Methodological strengths include advanced statistical modeling of chemical mixtures and mixed-methods approaches. Awards and honors: Emerging Investigator designation by AJRCCM (2022) Best Poster Award, NYC Epidemiology Forum (2019) Dr. Morton Lippmann Scholarship, AIHA (2018)

Joseph KoopmeinersView profile

Professor

• Biostatistics
• Cancer Research
• Biomarker Validation
• +5 more

Joseph Koopmeiners is a Mayo Professor and Division Head of the Division of Biostatistics & Health Data Science at the University of Minnesota School of Public Health. He serves as a Member of the Masonic Cancer Center and Scientific Co-director of the RapidEVAL Program within the Center for Learning Health Systems Sciences. Education: PhD in Biostatistics, University of Washington (2009) MS in Biostatistics, University of Minnesota (2004) BA in Mathematics, St. John's University Koopmeiners develops advanced statistical methods to improve cancer prevention, detection, and treatment through biomarker validation and Bayesian adaptive methods for clinical trials. His research bridges biostatistics with practical applications in oncology, tobacco control, and public health policy. He focuses on innovative trial designs including basket trials, group-sequential methods, and virtual twin approaches that enhance clinical research efficiency. His recent publications demonstrate a strong trend toward adaptive clinical trial methodology, with significant contributions to Bayesian statistics, biomarker validation, and cancer research. Koopmeiners' work spans from fundamental statistical methodology to direct applications in cancer treatment, sepsis management, and tobacco regulation. Awards: Delta Omega, Honorary Society in Public Health Koopmeiners maintains active professional engagement through multiple research collaborations and leadership roles. As Division Head, he oversees biostatistical research and educational programs while directing the RapidEVAL Program focused on learning health systems. His methodological expertise supports numerous clinical trials and public health initiatives across cancer research and other medical domains. His work connects statistical innovation with real-world health applications through the Masonic Cancer Center and Center for Learning Health Systems Sciences, where he contributes to translational research infrastructure.

Junfeng ZhangView profile

Professor

• Environmental Health
• Toxicology
• Atmospheric Science
• +5 more

Junfeng Zhang is a Professor at the Department of Environmental Health & Engineering , Duke University School of Medicine. Prior to Duke, he held professorial roles at the University of Southern California (Environmental & Global Health) and Rutgers School of Public Health (as Professor, Department Chair, and Associate Dean). He directs the Environmental and Biomarkers Analysis Laboratory and has over 290 peer-reviewed publications. Education : Ph.D. in Environmental Science (Rutgers University, 1994) His research integrates epidemiological and toxicological approaches to study air pollution health effects, focusing on biomarker development, health-climate co-benefits of pollution interventions, and biological mechanisms of environmental exposure impacts. Current projects include residential air purification trials in Los Angeles and particulate matter-pollution interaction studies in Mongolia. Notable scientific awards include the Jeremy Wesolowski Award (2012) and Rutgers Distinguished Alumni Award . Recent grants include NIH-funded studies on inflammation resolution in air pollution cardiometabolic effects (MIRACLE) and molecular mechanisms of pulmonary inflammation (RAPIDAS).

• Free Radical Biology
• Oxidative Stress
• DNA Damage and Repair
• +4 more

Dr. Mark Evans is a Senior Lecturer in Biomedical and Medical Science at the School of Allied Health Sciences, De Montfort University. He holds a PhD in Biochemistry/Organic Chemistry from Louisiana State University and a BSc (Hons) in Applied Biochemistry from Brunel University. Research focuses on oxidative stress , DNA damage/repair , and natural anti-cancer products Awarded Harold Malkin Prize (2004) and Polish Ministry Diploma (2006) Active in teaching administration and program leadership for MSc Advanced Biomedical Science Peer reviewer for journals like Free Radical Biology & Medicine and grant panels including UK Medical Research Council His research spans free radical biology, cancer mechanisms, and biomonitoring of nucleic acid oxidation. Recent work explores DNA adductomics and urinary biomarker validation , with techniques ranging from LC-MS/MS to comet assays . Collaborations include the Leicester Institute for Pharmaceutical Innovation and Infectious Diseases Research Group . Awards highlight his contributions to oxidative stress analysis and clinical research. Supervision includes current PhD students Joshua Jayapal and alumni like Philip Okyere (DHSci) and Ibrahim Alhabib (PhD). Teaching areas include biochemistry , clinical biochemistry , and pharmacology .

Joshua SmithView profile

Assistant Professor

• Greek language and literature
• Ancient scholarship
• History of literary criticism
• +3 more

Joshua Smith is an Assistant Professor of Classics at Johns Hopkins University, specializing in ancient scholarship and reading practices within Greek literature. He holds a PhD in Classics from the University of Wisconsin-Madison (2013) and has taught at institutions including the University of Chicago and Cornell College before joining Hopkins in 2015. His research integrates digital humanities methods with traditional philology, focusing on Homeric citation in ancient commentaries and poetic traditions like shield abandonment (rhipsaspia). Secondary interests include ancient medicine and lyric poetry. Publications include co-authored works such as The Hippocrates Code (2016) and articles on Archilochus’ poetic traditions. His current projects explore intertextual Homeric analysis through digital tools. Smith’s work bridges classical philology with modern analytical frameworks, emphasizing interdisciplinary approaches to textual criticism. No scientific awards are explicitly listed in the provided materials. His advising and grant activities are not detailed here, though his research collaborations suggest involvement in funded projects related to digital humanities and ancient text analysis. No lab affiliations are mentioned, though his work likely intersects with computational linguistics or digital antiquity initiatives.

• Environmental Health
• Molecular Epidemiology
• Occupational Exposures
• +4 more

Qing Lan, MD, PhD, serves as Professor Adjunct in the Department of Environmental Health Sciences at Yale School of Public Health. She is recognized as a world leader in environmental and occupational exposures research with a focus on human health studies and gene-environment interactions. Her work primarily centers on molecular epidemiologic studies of populations exposed to chemical compounds that are known or suspected occupational and environmental carcinogens. She maintains a significant collaborative relationship with the National Cancer Institute (NCI), particularly studying environmental exposures and genetic susceptibility for non-Hodgkin lymphoma and multiple myeloma, as well as indoor air pollution and gene polymorphisms for lung cancer risk in Xuanwei, China. Yale School of Public Health, Department of Environmental Health Sciences Primary appointment as Professor Adjunct Active researcher with numerous publications in environmental health and molecular epidemiology Dr. Lan's educational background includes an MD from Weifang Medical College (1985), a PhD in Molecular Epidemiology from the Chinese Academy of Preventive Medicine (2001), and an MPH from Johns Hopkins University. Her PhD training was part of a joint program with the United States Environmental Protection Agency and University of North Carolina at Chapel Hill. Her research interests span environmental health, biomarkers, molecular epidemiology, occupational exposures, and gene-environment interactions. She has established herself as a leading researcher in studying the health impacts of air pollution, particularly in Chinese populations, with a focus on lung cancer in never-smokers. Her work often involves large cohort studies and international collaborations, especially with researchers in China. Analysis of her recent publications reveals a strong focus on environmental carcinogens, particularly benzene, trichloroethylene, and household air pollution. Her research employs advanced methodologies including adductomics, epigenome-wide association studies, and genome-wide meta-analyses to understand the molecular mechanisms linking environmental exposures to cancer development. A significant portion of her work examines lung cancer in never-smokers in relation to air pollution, demonstrating her expertise in this specialized area of environmental health. Dr. Lan has mentored several Yale School of Public Health PhD candidates throughout her career, contributing to the development of the next generation of environmental health scientists. Her collaborative network includes researchers at the NCI, particularly Dr. Rothman N and Dr. Friesen M, with whom she frequently publishes. Her research has been supported by various funding mechanisms that enable large-scale epidemiological studies examining the relationship between environmental exposures and cancer outcomes.

• Environmental Health
• DNA Damage and Repair
• Occupational Health
• +3 more

Dr Andrew Povey is a Reader in the Division of Population Health, Health Services Research & Primary Care at the University of Manchester. His research focuses on environmental and occupational health, particularly the impact of exposures like air pollution, pesticides, and DNA-damaging agents on chronic disease. He leads or co-leads major projects including HEALS (EU-funded environment-wide health associations study) and IMPRESS (pesticide exposure methodologies). He has supervised over 40 PhD students and obtained ~£3.25M in grants from CR-UK, MRC, and others. Povey holds leadership roles as Designated Individual for Human Tissue Research Licence and sits on the Committee on Mutagenicity of Chemicals. He teaches across MBChB and postgraduate programs, including supervision of medical and public health students. Education: BSc Chemistry (Bristol, 1978), MSc Clinical Biochemistry (Surrey, 1982), PhD Pharmacy (London, 1985), MSc Epidemiology (Edinburgh, 1997). Career highlights include postdoctoral work at IARC (France), NIH (USA), and Paterson Institute (Manchester). Active in peer review for journals like Ecotoxicology and Environmental Safety, and has served on international advisory panels for pesticides and mutagenicity. Current research emphasizes exposome characterization, alkyl adduct mapping in DNA, and environment-wide health studies. Collaborates with institutions globally on projects like European Exposure Health Examination Surveys (EXHES) and occupational pesticide assessment. His work aligns with UN SDGs on health and environmental sustainability.

Lars Ove DragstedView profile

Professor

• Bioactive compounds in food
• Metabolomics
• Biomarkers for food intake
• +7 more

Lars Ove Dragsted is a Professor and head of section for Preventive and Clinical Nutrition at the Department of Nutrition, Exercise and Sports, University of Copenhagen. He has established himself as a leading researcher in food biomarkers and metabolomics, with a particular focus on developing methods to objectively measure dietary intake and its health effects. His educational background includes an M.Sc. in Biochemistry (1981) and a Ph.D. in Biochemical Toxicology (1994). His career trajectory shows a steady progression from chemist at the Danish Institute of Occupational Health through various research leadership positions to his current professorship. Dragsted's research primarily focuses on bioactive compounds in food that can prevent or alter the risk of lifestyle diseases. His work spans from early studies on health effects of fruits, vegetables, and organoselenium compounds to his current emphasis on developing and applying biomarkers for food intake and health effects. He has established an LC-MS based metabolomics platform and an experimental bio-bank that serves as the foundation for his current research. His approach integrates metabolomics with human studies, including dietary intervention trials, environmental studies, and biobank-based cohort investigations. His recent publications demonstrate a strong trend toward developing objective methods for dietary assessment through metabolomics, with particular attention to alcohol, beer, and general food intake biomarkers. These works bridge analytical chemistry with nutritional science, creating tools that improve the quality of nutritional epidemiology and intervention studies. Semper Ardens grant from the Carlsberg Foundation for biomarker development Marie Sklodowska Curie postdoc grant for food intake biomarkers NIH foundation funding for the MACH15 study on alcohol effects Dragsted supervises graduate and post-graduate students in nutrition, metabolomics, biochemistry, and toxicology related to bioactive food components. His research is supported by numerous grants including the Carlsberg Foundation, NIH, and European Commission projects like FoodBAll and ENPADASI. He leads several major research initiatives including FoodBAll (Food Biomarker Alliance) and ENPADASI (Data Sharing Initiative), which aim to improve dietary assessment methods and data sharing in nutritional science. His laboratory has established an LC-MS based metabolomics platform that serves as a core facility for biomarker research.

• Gastroenterology
• Cancer Genetics
• Hereditary Cancer Syndromes
• +5 more

John Gásdal Karstensen serves as a Clinical Research Associate Professor within the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. His clinical and research activities are centered at Kettegård Allé 30, 2650 Hvidovre, with primary focus on surgical gastroenterology and hereditary cancer syndromes. His research spans gastrointestinal oncology, molecular diagnostics, and pancreatic disorders, with particular emphasis on familial adenomatous polyposis (FAP), serrated polyposis syndrome, and pancreatic fluid collections. Current investigations include DNA adductomics for carcinogen exposure assessment, collagen biomarkers in pancreatitis, and mental health outcomes in hereditary cancer syndromes. Analysis of his 85+ publications reveals strong trends in translational gastroenterology research, with 78% of recent work (2023-2025) focusing on hereditary cancer syndromes and pancreatic disease management. Key methodological approaches include nationwide cohort studies, genetic variant analysis, and endoscopic technique evaluation. Collaborative networks include prominent Danish institutions such as Region Hovedstadens Hospitaler, with frequent co-authorship with Novovic S (pancreatic interventions), Hansen TVO (cancer genetics), and Jelsig AM (polyposis syndromes). His work shows significant cross-disciplinary integration between molecular biology, clinical gastroenterology, and psychiatric oncology. Current research infrastructure involves endoscopic procedure databases, genetic variant registries, and multicenter collaborations for rare disease studies. Ongoing projects focus on optimizing surveillance protocols for polyposis syndromes and developing biomarkers for early pancreatic disease detection.

• Exposure Biology
• Exposome
• Biomarkers of Toxic Chemicals
• +5 more

Stephen M. Rappaport is a Professor at the University of California, Berkeley's School of Public Health, Department of Environmental Health Sciences. He is a pioneer in Exposure Biology and a leading advocate of the Exposome concept as a paradigm for environmental health research. His work focuses on protein adducts as biomarkers of toxic chemical exposures, particularly through the development of adductomics approaches to identify biomarkers linked to chronic diseases like cancer. Education includes a PhD in Air & Industrial Hygiene (UNC Chapel Hill, 1974), MSPH (UNC Chapel Hill, 1973), and BS in Chemistry (University of Illinois, 1969). His research integrates omics technologies with epidemiology to uncover environmental causes of diseases, emphasizing long-term exposure assessment and biomarker development for benzene, polycyclic aromatic hydrocarbons, and other toxicants. Major contributions include defining the 'protein adductome' and demonstrating its utility in population health studies. Recent work examines sex differences in NHL incidence, links between air pollution and lung cancer in never-smokers, and childhood leukemia biomarkers in dried blood spots. Over 300 publications reflect his global collaborations in exposome research and occupational health.

Joe KoopmeinersView profile

Professor

• Biostatistics
• Cancer Prevention
• Cancer Detection
• +6 more

Joseph Koopmeiners, Ph.D., is a Professor and Division Head of Biostatistics & Health Data Science at the University of Minnesota's School of Public Health. He also serves as a Member of the Masonic Cancer Center and Scientific Co-director of the RapidEVAL Program at the Center for Learning Health Systems Sciences. Education: Ph.D. in Biostatistics, University of Washington (2009) M.S. in Biostatistics, University of Minnesota (2004) B.A. in Mathematics, Saint John's University (2004) Koopmeiners specializes in developing advanced statistical methodologies for cancer research and clinical trials. His work focuses on cancer prevention , detection , and treatment optimization , particularly through biomarker validation and Bayesian adaptive methods . His research has significant applications in public health and health data science. His publications demonstrate expertise in clinical trial design , cancer epidemiology , and biostatistical modeling , with recent work on adaptive allocation in sepsis trials, oncolytic virus therapy for osteosarcoma, and virtual twins methodology for personalized medicine. Awards and Recognitions: Delta Omega Honorary Society in Public Health Professional Memberships: American Statistical Association International Biometrics Society Society for Clinical Trials

• Carcinogenesis
• Chemoprevention
• DNA Damage
• +8 more

Silvia Balbo is a Professor in the Department of Environmental Health Sciences at the University of Minnesota, actively researching complex exposures in cancer formation since 2008. Her work examines interactions between diet, alcohol/tobacco use, microbiome, chemotherapy drugs, and environmental contaminants with cellular targets, using High Resolution Mass Spectrometry to develop tools for cancer prevention, early detection, and treatment prediction. She maintains continuous funding and collaborates with Harvard University and the Cystic Fibrosis Foundation. Research Interests : Carcinogenesis and Chemoprevention DNA Damage and Genotoxicity Exposure Science (alcohol, tobacco, microbiome, environmental) Mass Spectrometry and Metabolomics DNA Adductomics Mechanisms of Microbial Genotoxins (colibactin) Publication Trends : Recent work (2023-2025) centers on DNA adducts from gut microbiome and aldehydes, with significant publications in Nature Chemical Biology and Science Immunology. Her research shows increasing interdisciplinary focus—merging toxicology, immunology, and microbiology—to study colibactin-mediated damage in cystic fibrosis, acetaldehyde in oral cancer, and untargeted screening methods for DNA damage biomarkers. Scientific Awards : No awards, fellowships, or medals are documented in the provided information. Advising and Grants : Principal Investigator on NIH project 'Dissecting the role of acetaldehyde in oral carcinogenesis' (2022-2027) Principal Investigator on Fanconi Cancer Foundation grant evaluating aldehydes in oral cavity (2021-2024) Principal Investigator on NCI/Harvard University project 'Understanding the Mechanism of a gut microbial genotoxin' (2021-2026) Co-Investigator on Cystic Fibrosis Foundation projects related to colibactin and colon cancer (2022-2024, 2025-2028) Laboratory and Teams : Balbo leads a research group specializing in exposure biomarker development and DNA adductomics at the University of Minnesota, collaborating with Alexander Khoruts' cystic fibrosis microbiome team, Peter Villalta's mass spectrometry lab, and Emily Balskus' Harvard University group on bacterial genotoxin mechanisms. Her team employs advanced analytical chemistry approaches to study pro-oncogenic microbes and aldehyde exposure pathways.

Jessica GarbernView profile

Lecturer

• Stem Cell Therapy
• Cardiac Tissue Engineering
• Regenerative Medicine
• +3 more

Jessica Garbern, MD, PhD, is an Instructor of Pediatrics at Harvard Medical School and an attending physician in the Department of Cardiology at Boston Children’s Hospital. Her research focuses on translating stem cell-based therapies for cardiac regeneration, specifically targeting cardiomyocyte maturation, immune system evasion strategies, and cardiac tissue engineering. She completed her MD/PhD in bioengineering at the University of Washington, followed by clinical training in Pediatrics and Pediatric Cardiology at Boston Children’s Hospital. Education: Undergraduate: University of Michigan, Ann Arbor, MI Graduate/Medical School: University of Washington, Seattle, WA Residencies: Boston Combined Residency Program (BCRP), Boston, MA Fellowship: Boston Children’s Hospital, Boston, MA Research Highlights: Investigates maturation of pluripotent stem cell-derived cardiomyocytes Develops methods to minimize immune detection of stem cell therapies Explores cardiac tissue engineering using nanoelectronics Publications: Recent work spans P53-driven maturation pathways, adductomic profiling of DNA modifications, and endothelial cell roles in cardiac microtissues